Ceftriaxone vs Cefuroxime for Infection Prophylaxis in Coronary Bypass Surgery
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Thoracic and Cardiovascular Surgery
- Vol. 28 (3-4) , 143-148
- https://doi.org/10.3109/14017439409099119
Abstract
The most serious infection after coronary artery bypass grafting (CABG) is mediastinitis following deep sternal wound infection. Antibiotic prophylaxis for at least 48 hours has been recommended. In this trial 551 consecutive patients were randomized to receive ceftriaxone in a single dose or cefuroxime thrice daily until the end of the second postoperative day. The overall infection rate was 7.7% in the ceftriaxone and 8.3% in the cefuroxime group, and the incidence of deep sternal infection was 2.9% in both groups. Significant risk factors for such infection were chronic respiratory disease (p < 0.001) and diabetes (p <0.01). The antibiotic prophylaxis had no harmful effects on the colonic flora in either group. Acquisition and delivery costs for the prophylactic agents were three times higher in the cefurcxime than in the ceftriaxone group. Both antibiotics are concluded to be equally safe and effective. Single-dose ceftriaxone prophylaxis is as effective as cefuroxime given for 48 hours postoperatively. Single-dose ceftriaxone is also simple to use.Keywords
This publication has 19 references indexed in Scilit:
- Antibiotic prophylaxis in cardiac operationsThe Annals of Thoracic Surgery, 1993
- The Timing of Prophylactic Administration of Antibiotics and the Risk of Surgical-Wound InfectionNew England Journal of Medicine, 1992
- Antimicrobial Prophylaxis in Coronary Bypass Surgery: A Critical AppraisalDICP, 1991
- Hospital Reimbursement Patterns among Patients with Surgical Wound Infections following Open Heart SurgeryInfection Control & Hospital Epidemiology, 1990
- Sternal wound complications after isolated coronary artery bypass grafting: Early and late mortality, morbidity, and cost of careThe Annals of Thoracic Surgery, 1990
- Ceftriaxone disposition in open-heart surgery patientsAntimicrobial Agents and Chemotherapy, 1989
- Efficacy of Cefazolin, Cefamandole, and Gentamicin as Prophylactic Agents in Cardiac SurgeryAnnals of Surgery, 1987
- Antimicrobial Prophylaxis in Cardiovascular SurgeryThe Thoracic and Cardiovascular Surgeon, 1987
- On Antibiotic Prophylaxis in Cardiac Surgery: A Risk Factor for Wound InfectionThe Annals of Thoracic Surgery, 1986
- The Economic Implications of Infection in Cardiac SurgeryThe Annals of Thoracic Surgery, 1986